CRISPR gene editing technology

GPTKB entity

Statements (64)
Predicate Object
gptkbp:instance_of gptkb:biotechnology
gptkbp:allows targeted gene modification
gptkbp:based_on gptkb:CRISPR-Cas9_system
gptkbp:business_model germline editing
genetic modification
designer babies
gptkbp:can_be_used_to study gene function
create genetically modified organisms
develop gene therapies
gptkbp:collaborated_with gptkb:scientists
universities
research institutions
gptkbp:developed_by gptkb:Emmanuelle_Charpentier
gptkb:Jennifer_Doudna
gptkbp:enables gene replacement
gene insertion
gene knockout
gptkbp:has_applications_in crop improvement
disease treatment
gptkbp:has_limitations off-target effects
regulatory hurdles
delivery methods
https://www.w3.org/2000/01/rdf-schema#label CRISPR gene editing technology
gptkbp:influences future of medicine
future of agriculture
future of biotechnology
gptkbp:is_advancing_in agricultural biotechnology
therapeutic applications
industrial biotechnology
gptkbp:is_applied_in gptkb:biotechnology
gptkb:Medicine
agriculture
gptkbp:is_associated_with biomedical research
genetic engineering
molecular genetics
gptkbp:is_challenged_by gptkb:political_debates
gptkb:public_opinion
ethical dilemmas
gptkbp:is_explored_in gptkb:literature
conferences
patents
gptkbp:is_part_of gptkb:biotechnology
molecular biology
genomics
gptkbp:is_popular_in universities
research institutions
biotech companies
gptkbp:is_promoted_by advocacy groups
scientific organizations
biotech firms
gptkbp:is_regulated_by government agencies
ethical committees
gptkbp:is_subject_to regulatory scrutiny
legal challenges
patent disputes
gptkbp:is_supported_by gptkb:venture_capital
funding agencies
government grants
gptkbp:is_used_in clinical trials
agricultural research
pharmaceutical development
gptkbp:used_for genome editing
gptkbp:bfsParent gptkb:Science_magazine
gptkbp:bfsLayer 5